TTL Beteiligungs- und Grundbesitz-AG (FRA:TTO)

Intra-Cellular Therapies Revenue

TTL Beteiligungs- und Grundbesitz-AG had revenue of 625.00K EUR in the half year ending June 30, 2024, a decrease of -31.62%. This brings the company's revenue in the last twelve months to 1.26M, down -41.75% year-over-year. In the year 2023, TTL Beteiligungs- und Grundbesitz-AG had annual revenue of 1.29M, down -46.63%.

• Revenue (ttm): 1.26M
• Revenue Growth: -41.75%
• P/S Ratio: 3.33
• Revenue / Employee: 628.50K
• Employees: 2
• Market Cap: 4.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.29M	-1.13M	-46.63%
Dec 31, 2022	2.42M	771.00K	46.90%
Dec 31, 2021	1.64M	-1.55M	-48.51%
Dec 31, 2020	3.19M	2.02M	171.98%
Dec 31, 2019	1.17M	569.00K	94.05%